Regeneron 20118
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 24, 2021
End Date
December 31, 2024
Administered By
Duke Clinical Research Institute
Awarded By
Regeneron Pharmaceuticals, Inc.
Start Date
February 24, 2021
End Date
December 31, 2024